DNMT3B and ICF syndrome: This latter hypothesis is based on analyses of hypomethylated cells obtained either from cells treated with DNA-methyltransferase inhibitors (5-azacytidine) or from cells from patients with ICF syndrome who have mutations in the DNA methyltransferase 3b gene (DNMT3B).